User:WikiLinuz/Psychoactive substances/Methamphetamine

Harm potential and pharmacology

• Matthew K, Erik G, Chris J, Frances L, Richard F, Carl H (2 November 2011). "Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans". Addiction: 783–791. doi:10.1111/j.1360-0443.2011.03706.x.
• Martin R, Sloan W, Sapra D, Jasinksi R (March 1971). "Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man". Clinical Pharmacology & Therapeutics. 12 (2): 245–258. doi:10.1002/cpt1971122part1245.
• Lamb J, Henningfield E (March 1994). "Human d-amphetamine drug discrimination: methamphetamine and hydromorphone". Journal of the Experimental Analysis of Behavior. 61 (2): 169–180. doi:10.1901/jeab.1994.61-169.
• Boris S, Mario S (2007). "Dual intoxication with diazepam and amphetamine: This drug interaction probably potentiates myocardial ischemia". Medical Hypotheses. 69 (2): 377–380. doi:10.1016/j.mehy.2006.12.033.
• Shawn G, Gaynor L, Jarod S, Namita S, Jonathan J, Nancy Z, Louis F, Habibeh K (January 2009). "Amphetamine and Methamphetamine Differentially Affect Dopamine Transporters in Vitro and in Vivo". Journal of Biological Chemistry. 284 (5): 2978–2989. doi:10.1074/jbc.M805298200.{{cite journal}}: CS1 maint: unflagged free DOI (link)
• Khursheed A, Errol S. "Pharmacology and Toxicology of Amphetamine and Related Designer Drugs" (PDF). National Institute on Drug Abuse. Archived (PDF) from the original on 11 May 2023. Retrieved 11 May 2023.
• John R, Erik L. Methamphetamine Toxicity. StatPeals.
• David H, Sharon S, Jane G, David N (28 March 2013). "Amphetamine, past and present – a pharmacological and clinical perspective". Journal of Psychopharmacology. 27 (6). doi:10.1177/0269881113482532.
• Colin D, Andrew G, Tong L, Everett E (27 March 2001). "Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment". Brian Research Reviews. doi:10.1016/s0165-0173(01)00054-6. PMID 11516769.
• Shaobin Y, Ling Z, Quiang S, Xue B, Xuhui D (12 May 2015). "Recent Advances in Methamphetamine Neurotoxicity Mechanisms and Its Molecular Pathophysiology". Behavioural Neurology. doi:10.1155/2015/103969. PMID 25861156.{{cite journal}}: CS1 maint: unflagged free DOI (link)
• Martin R, Lily M, Elizabeth J, Kelly H, Lawrence M, Patricia S. "Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment". Journal of Neurochemistry. doi:10.1046/j.1471-4159.2001.00549.x. PMID 11595767.
• Hogan K, Staal G, Sonsalla K. "Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations". Journal of Neurochemistry. doi:10.1046/j.1471-4159.2000.0742217.x. PMID 10800969.
• Albers S, Sonsalla K (1 December 1995). "Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents". Journal of Pharmacology and Experimental Therapeutics. 275 (3). PMID 8531070.
• Albers S, Zeevalk D, Sonsalla K. "Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP". Brain Research. 718 (1). doi:10.1016/0006-8993(96)00135-7. PMID 8773791.

Clinical application

• Thomas R, Aakrti K, Li Z, Sarah U, Saskia J, Diane B, Fernando C, Michael C, David P (27 May 2011). "Low dose methamphetamine mediates neuroprotection through a PI3K-AKT pathway". Neuropharmacology. doi:10.1016/j.neuropharm.2011.05.010. PMID 21635908.
• Thomas R, John Z, David P (4 January 2016). "The neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 64: 231–236. doi:10.1016/j.pnpbp.2015.02.013.
• Regina B, Gary L (11 June 2009). "Methamphetamine and Fluoxetine Treatment of a Child with Attention-Deficit Hyperactivity Disorder and Obsessive-Compulsive Disorder". Journal of Child and Adolescent Psychopharmacology. 3 (1). doi:10.1089/cap.1993.3.53.
• Shichen S, Ming Z, Min M, Sailee R, David P, Jun Q (February 2021). "Potential Neuroprotective Mechanisms of Methamphetamine Treatment in Traumatic Brain Injury Defined by Large-Scale IonStar-Based Quantitative Proteomics". International Journal of Molecular Sciences. doi:10.3390/ijms22052246. PMC 7956755. PMID 33668155.{{cite journal}}: CS1 maint: unflagged free DOI (link)
• Bita S, Marzieh S, Holamhossei R, Nahid M (March 2022). "Protective Effect of Low Dose of Methamphetamine on The Amount of Extracellular Glutamine in Primary Fetal Human Astrocytes Induced by Amyloid Beta". Cell Journal. doi:10.22074/cellj.2022.7917. PMC 9035228. PMID 35451579.
• Bita S, Marzieh D, Gholam H, Nahid M (10 August 2021). "Alteration of gene expression in reactive astrocytes induced by Aβ1-42 using low dose of methamphetamine". Molecular Biology Reports. PMID 34374897.
• Paul W (11 June 2009). "Methamphetamine in Child Psychiatry". Journal of Child and Adolescent Psychopharmacology. 3 (1): 4–6. doi:10.1089/cap.1993.3.iv.
• "Compound summary: DL-Methamphetamine". PubChem.
• "DESOXYN: Methamphetamine HCL tablet". DailyMed.
• "FDA: DESOXYN Methamphetamine HCL tablet" (PDF). Food and Drug Administration.

Adverse reaction reduction

• Colin D, Quiang C, Xiuwn Z, Xueying X, Cindy L, Tong HL, Everett HE. "Deprenyl treatment attenuates long-term pre- and post-synaptic changes evoked by chronic methamphetamine". European Journal of Pharmacology.
• Delle T, Sonsalla K (1 December 1994). "Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation". Journal of Pharmacology and Experimental Therapeutics. 271 (3). PMID 7996441.
• Chutikorn N, Anuttree B, Jiraporn P, Piyart G (June 2022). "Melatonin Attenuates Methamphetamine-Induced Alteration of Amyloid β Precursor Protein Cleaving Enzyme Expressions via Melatonin Receptor in Human Neuroblastoma Cells". Neurotoxicity Research. doi:10.1007/s12640-022-00522-6. PMID 35648367.
• Terleckyj I, Sonsalla K (1 April 1994). "The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors". Journal of Pharmacology and Experimental Therapeutics. 269 (1). PMID 7513362.
• Dong S, Qingwei Y, Weihua G, Tao L, Jing Z, Guibao L, Zengxun L, Jinhao S (July 2015). "Neuroprotection of resveratrol against neurotoxicity induced by methamphetamine in mouse mesencephalic dopaminergic neurons". BioFactors. doi:10.1002/biof.1221. PMID 26212417.
• Taizo K, Masato A, Ikuko M, Mika T (March 2014). "Protective effects of phytochemical antioxidants against neurotoxin-induced degeneration of dopaminergic neurons". Journal of Pharmacological Sciences. doi:10.1254/jphs.13r19cp. PMID 24599140.
• Mitsugi O, Hiroshi K, Emi K, Haruki S, Toshiaki K, Akinori A (February 2007). "Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults". Biochemical Pharmacology. 73 (4). doi:10.1016/j.bcp.2006.11.003. PMID 17147953.
• Pattama P, Chutikorn N, Kannika P, Jatuporn N, Piyart G (September 2021). "Melatonin protects against methamphetamine-induced Alzheimer's disease-like pathological changes in rat hippocampus". Neurochemistry International. 148. doi:10.1016/j.neuint.2021.105121. PMID 34224806.
• Sonsalla K, Riordan E, Heikkila E. "Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice". Journal of Pharmacology and Experimental Therapeutics. 256 (2). PMID 1671596.
• Paola C, Camilla M, Alberto C, Angelo C, Palo C, Maria S, Liana F, Paola F, Grazia E (20 May 2014). "Δ9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity". PLOS One. doi:10.1371/journal.pone.0098079. PMID 24844285.{{cite journal}}: CS1 maint: unflagged free DOI (link)
• Tyler W, Ian P, Paxton B (31 January 2022). "Avoidance of β-blockers in patients who use stimulants is not supported by good evidence". Canadian Medical Association Journal. 194 (4). doi:10.1503/cmaj.211347. PMID 35101873.
• Chen H, Yu C (August 2011). "Restorative effect of Acetyl-L-Carnitine on behavioral deficits and neurotoxicity induced by a neurotoxic dose regimen of methamphetamine". Journal of Neurochemistry. doi:10.1111/j.1471-4159.2011.07326.x.
• Diego A, Litizia P, Alessandra S, Gianluigi F (September 2010). "Neuroprotective properties of resveratrol in different neurodegenerative disorders". BioFactors. doi:10.1002/biof.118. PMID 20848560.